Skip to main content

Heart Failure and Kidney Disease: Management in the Short-Stay Unit

  • Chapter
  • First Online:
Short Stay Management of Acute Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1100 Accesses

Abstract

Heart failure and kidney disease are among the fastest-growing diagnoses in the United States. Recent data indicate that more than half of heart failure patients have underlying kidney dysfunction. The presentation of a patient with acute heart failure and concomitant kidney disease describes one of the most complex patients to manage. Unfortunately, there are no guidelines for managing this patient population. Current treatment options for managing acutely decompensated heart failure focus on improving cardiac function through reductions in preload and afterload. Medical therapy in patients with heart failure and CKD is similar but with a few important differences. This chapter explores diagnostic, therapeutic, and prognostic considerations that should be employed when dealing with this patient population. Although there are well-established guidelines for managing heart failure and kidney disease alone, the lack of significant randomized clinical trials guiding management of their copresentation in the emergency department and short-stay unit has slowed development of evidence-based treatments. This chapter will mainly focus on the additional management of patients with heart failure and concomitant kidney disease in the short-stay unit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National chronic kidney disease fact sheet. http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm. Accessed 12 Nov 2010.

  2. Kidney and urological disease statistics in the United States. http://kidney.niddk.nih.gov/statistics. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Accessed 12 Nov 2010.

  3. United States Renal Data System. 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2015.

    Google Scholar 

  4. Bagshaw SM, Cruz DN, Aspromonte N. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010;25(5):1406–16.

    Article  PubMed  Google Scholar 

  5. Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communicates (ARIC) study. J Am Soc Nephrol. 2007;18(4):1307–15.

    Article  CAS  PubMed  Google Scholar 

  6. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizations. N Engl J Med. 2004;351:1296–305.

    Article  CAS  PubMed  Google Scholar 

  7. Glomerular filtration rate. http://www.kidney.org/kidneydisease/ckd/knowGFR.cfm. Accessed 12 Nov 2010.

  8. Astor BC, Levey AS, Stevens LA, et al. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20:2214–22.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–46.

    Article  CAS  PubMed  Google Scholar 

  10. Stevens LA, Coresh J, Schmid CH, et al. A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure. J Am Coll Cardiol. 2006;47:1987–96.

    Article  PubMed  Google Scholar 

  12. Herzog CA, Asinger RW, Berger AK, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80(6):572–86.

    Article  PubMed  Google Scholar 

  13. Cerasola G, Nardi E, Palermo A, et al. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol. 2011;24:1–10.

    Article  PubMed  Google Scholar 

  14. McAlister FA, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure. Circ. 2004;109:1004–9.

    Article  Google Scholar 

  15. Wali RK, Wang GS, Gottlieb SS, et al. Effect of kidney transplantation on left ventricular systolic function and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005;45:1051–60.

    Article  PubMed  Google Scholar 

  16. Hillege HL, Girbes ARJ, de Kam PJ, et al. Renal function, neurohormonal activation, and survival; in patients with chronic heart failure. Circulation. 2000;102:203–10.

    Article  CAS  PubMed  Google Scholar 

  17. The national kidney foundation: kidney disease outcomes quality initiative. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p7_risk_g15.htm. Accessed 2 Dec 2010.

  18. Damman K, Tang WH, Felker M. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency. J Am Coll Cardiol. 2014;63(9):853–71.

    Article  PubMed  Google Scholar 

  19. de Filippi CR, Christenson RH. B-type natriuretic peptide (BNP)/NT-proBNP and renal function: is the controversy over? Clin Chem. 2009;55:1271–3.

    Article  Google Scholar 

  20. Wu AH, Jaffe AS, Apple FS, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem. 2007;53:2086–96.

    Article  CAS  PubMed  Google Scholar 

  21. Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis dependent CRF. The Am J of Kid Dis. 2004;44(3):2420–8.

    Article  Google Scholar 

  22. de Filippi CR, Seliger SL, Maynard S, et al. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem. 2007;53:1511–9.

    Article  Google Scholar 

  23. McCullough PA, Nowak RM, Foreback C, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med. 2002;9:1389–96.

    Article  PubMed  Google Scholar 

  24. Dadkhah S, Sharain K, Sharain R, et al. The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes. Crit Pathw Cardiol. 2007;6:76–84.

    Article  PubMed  Google Scholar 

  25. Roberts MA, Hare DL, Macmillan N, et al. Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis. Ann Clin Biochem. 2009;46:291–5.

    Article  CAS  PubMed  Google Scholar 

  26. Aslam F, Haque A, Haque J, et al. Heart failure in subjects with chronic kidney disease: best management practices. World J Cardiol. 2010;2(5):112–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Koniari K, Nikolaou M, Paraskevaidis I, et al. Therapeutic options for the management of the cardiorenal syndrome. Int J Nephrol. 2010;2011:194910.

    PubMed  PubMed Central  Google Scholar 

  28. Badve SV, Roberts MA, Hawley CM, et al. Effects of beta adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(11):1152–61.

    Article  CAS  PubMed  Google Scholar 

  29. Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. BioMed Res Int. 2014; 1–21.

    Google Scholar 

  30. Bonow RO, Bennett S, Casey Jr DE, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American college of cardiology/American heart association task force on performance measures (writing committee to develop heart failure clinical performance measures). Circulation. 2005;112:1853–87.

    Article  PubMed  Google Scholar 

  31. Berger AK, Duval S, Manske C, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J. 2007;153:1064–73.

    Article  CAS  PubMed  Google Scholar 

  32. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Arch Intern Med. 2000;160:685–93.

    Article  CAS  PubMed  Google Scholar 

  33. Khan NA, Ma I, Thompson CR, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol. 2006;17(1):244–53.

    Article  PubMed  Google Scholar 

  34. Witteles RM. Nesiritide, heart failure, and renal dysfunction: irrational exuberance or throwing the baby out with the bathwater. Cardiovasc Drugs Ther. 2009;23:183–6.

    Article  PubMed  Google Scholar 

  35. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004;110:1620–5.

    Article  CAS  PubMed  Google Scholar 

  36. Sackner-Bernstein JD, Skopicki HA, Arronsson KD, et al. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487–91.

    Article  CAS  PubMed  Google Scholar 

  37. Riter HG, Redfield MM, Burnett JC, et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. 2006;47:2334–42.

    Article  CAS  PubMed  Google Scholar 

  38. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. J Am Coll Cardiol. 2007;49:716–26.

    Article  CAS  PubMed  Google Scholar 

  39. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. J Am Med Assoc. 2002;287:1531–40.

    Google Scholar 

  40. Peacock WF, Holland R, Gyamarthy R, et al. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. J Emerg Med. 2005;29:243–52.

    Article  PubMed  Google Scholar 

  41. Peacock WF, Emerman CL, Silver MA. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med. 2005;23:327–31.

    Article  PubMed  Google Scholar 

  42. Hernandez AF. Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010: ASCEND-HF. Clin Res Cardiol. 2011;100(1):1–9.

    Article  Google Scholar 

  43. Mohammed SF, Korinek J, Chen HH, et al. Nesiritide in acute decompensated heart failure: current status and future perspectives. Rev Cardiovasc Med. 2008;9(3):151–8.

    PubMed  PubMed Central  Google Scholar 

  44. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501–10.

    Article  PubMed  Google Scholar 

  45. Young JB, Abraham WT, Albert NM, et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol. 2008;101:223–30.

    Article  CAS  PubMed  Google Scholar 

  46. Schmid H, Schiffl H, Lederer SR. Erythropoiesis stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):465–70.

    Article  CAS  PubMed  Google Scholar 

  47. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339(9):584–90.

    Article  CAS  PubMed  Google Scholar 

  48. Singh AK, Szczech L, Tange KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Eng J Med. 2006;355(20):2085–98.

    Article  CAS  Google Scholar 

  49. Drueke TB, Locaelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071–84.

    Article  CAS  PubMed  Google Scholar 

  50. Silverberg DS, Wexler D, Iaina A, et al. The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Clin Exp Nephrol. 2009;13:101–6.

    Article  CAS  PubMed  Google Scholar 

  51. Locatelli F, Aljama P, Canaud B, et al. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the trial to reduce cardiovascular events with aranesp therapy (TREAT) study. Nephrol Dial Transplant. 2010;25(9):2846–50.

    Article  PubMed  Google Scholar 

  52. American Heart Association. Heart disease and stroke statistics—2005 update. Dallas: American Heart Association; 2005.

    Google Scholar 

  53. Desai A, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012;126:501–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahriar Dadkhah MD, FACC .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dadkhah, S., Sharain, K. (2017). Heart Failure and Kidney Disease: Management in the Short-Stay Unit. In: Peacock, W. (eds) Short Stay Management of Acute Heart Failure. Contemporary Cardiology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-44006-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44006-4_23

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-44005-7

  • Online ISBN: 978-3-319-44006-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics